InStar Technologies is an Czech pharmaceutical company which developed innovative and patented OTF (Oral Thin Film) active substances delivery technology. Our innovative, cutting edge InStrip Technology is revolutionizing OTF market by introducing the possibility of oromucosal delivery of active substances ranging from nutraceuticals, small molecule to peptides and proteins (including vaccines). The versatility of InStrip technology will create limitless opportunities for OTF products and can significantly increase the global market by the inclusion of lipophilic products (creates majority of global market) which is a challenge for current OTF technologies. InStar’s technology is the much-needed catalyst to increase the OTF market size and its inclusion in different healthcare segments in upcoming years. The ability to reformulate and improve existing active substances means lower development, storage and transport costs and higher chance to market. The technology is validated through established partnerships, European grants, pre-clinical and clinical trial.
